Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website https://www.jofem.org

Original Article

Volume 13, Number 2, June 2023, pages 49-56


Efficacy of I-131 Treatment Dosage for Hyperthyroidism With Current Institution Formula

Tables

Table 1. Baseline Characteristics of Patients With Radioactive Iodine Therapy (n = 89)
 
Age (mean ± SD)48.7753 ± 13.26286
SD: standard deviation.
Gender, n %
  Females74 (83.1%)
  Males15 (16.9%)
Ethnicity, %
  Chinese1.1%
  Declined2.2%
  Ecuadorian1.1%
  Filipino2.2%
  Guatemalan1.1%
  Mexican/Mexican American4.5%
  Non-Hispanic52.8%
  Other Hispanic1.1%
  Salvadoran2.2%
  Unknown31.5%
Preliminary diagnosis, %
  Graves with thyrotoxicosis1.1%
  Graves’ disease67.4%
  Hyperthyroidism2.2%
  Multinodular goiter3.4%
  Multinodular goiter or thyroid adenoma1.1%
  Questionable toxic thyroid nodule1.1%
  Subclinical hyperthyroidism1.1%
  Thyrotoxicosis2.2%
  Toxic multinodular goitre10.1%
  Toxic thyroid nodule10.1%
Thyroid uptake percentage (mean ± SD)62.03 ± 23.89

 

Table 2. Univariate Post-Ablation Analysis
 
Dosage (I-131) in mCiN%
10.6011.1%
15.0022.2%
20.0011.1%
25.0011.1%
30.0011.1%
31.0011.1%
39.7011.1%